Click me
Transcribed

Bladder Cancer: Profile and Drug Development

ISR reports Bladder Cancer profile and drug development www.ISRreports.com What is Bladder Cancer? Bladder Cancer forms in the layers of the bladder wall, most commonly the innermost urothelium layer. The cancer is described and treated based on how far it has moved into the wall of the bladder, - Bladder Cancer is the 9th most common cancer worldwide, with about 430,000 diagnosed each year. That's equivalent to the population of Raleigh, NC 9 out of 10 people with bladder cancer are over the age of 55 smoking workplace exposure to carcinogens age other urothelial Risk Factors cancers gender ethnicity chronic bladder infection genetics race general hematuria frequent urination irritation during urination Symptoms urgency advanced inability to urinate lower back pain loss of appetite weight loss foot swelling bone pain Finding bladder cancer early increases the chance of successful treatment. Screening tests include urinalysis, urine cytocology, and urine tests for tumor markers. Treatment Surgery is used in nearly all cases of bladder cancer, and is often combined with other types of treatment including: intravesical therapy, chemotherapy, and radition therapy. After surgery, new cancers can form in the bladder over time. The only way to avoid this is a radical cystectomy, or removal of the bladder, which can have major side effects. survival 5 year rate colorectal: 64% pancreatic: 6% bladder: 77% by stage breast: 89% Stage I: 88% Stage II: 63% Stage III: 46% Stage IV: 15% lung: 16% Future The molecular pathogenesis of bladder cancer is increasingly well understood, but translation of this knowledge into effective biomarkers and therapies has been largely unsuccessful. Therapies in development for the treatment of bladder cancer include: -Angiogenesis inhibition -Growth factor inhibitors Learn more about therapies in active development in ISR's -Immunotherapeutics -Gene therapy "Bladder Cancer Disease and Pipeline Analysis Report" There are currently 110 active studies with bladder cancer. ISR reports Sources:ISR Reports, seer.cancer.gov, cancer.org [email protected] @ISRREPORTS ISRREPORTS.COM

Bladder Cancer: Profile and Drug Development

shared by ISRreports on Jul 02
193 views
0 share
0 comments
ISR explores risk factors, treatment options, and future development in this infographic.

Category

Other
Did you work on this visual? Claim credit!

Get a Quote

Embed Code

For hosted site:

Click the code to copy

For wordpress.com:

Click the code to copy
Customize size